Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 54.00
-0.20 (-0.37%)
May 29, 2026, 1:30 PM CST
Sagittarius Life Science Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -30.56 | -49.56 | -48.53 | -55.04 | -74.2 | -86.42 |
Depreciation & Amortization | 8.58 | 10.34 | 14.76 | 15.03 | 20.92 | 24.18 |
Loss (Gain) From Sale of Assets | 0.03 | 0.13 | -2.98 | 0.08 | -0.01 | 0.01 |
Loss (Gain) From Sale of Investments | 1.7 | 0.47 | - | - | - | - |
Loss (Gain) on Equity Investments | - | - | - | - | 2.98 | - |
Other Operating Activities | -3.67 | -3.77 | -3.66 | -3.37 | -3.44 | -1.19 |
Change in Accounts Receivable | -39.38 | 33 | -3.52 | -1.25 | 6.29 | 17.37 |
Change in Inventory | -5.46 | 22.03 | 0.49 | -3.6 | 0.63 | 4.31 |
Change in Accounts Payable | -18.51 | -54.84 | -3.97 | -13.36 | -5.23 | 24.81 |
Change in Other Net Operating Assets | -8.91 | 6.15 | 2.94 | -7.87 | -0.83 | -12.25 |
Operating Cash Flow | -96.18 | -36.05 | -44.48 | -69.37 | -52.89 | -29.18 |
Capital Expenditures | -0.09 | -0.4 | -3.29 | -2.01 | -1.09 | -8.22 |
Sale of Property, Plant & Equipment | 3.77 | 3.77 | - | - | 0.06 | 0.09 |
Divestitures | 3.28 | 3.28 | - | - | 2 | - |
Sale (Purchase) of Intangibles | - | - | -0.51 | - | - | -0.21 |
Investment in Securities | -472.7 | -573.59 | 3.08 | 20.96 | -3.57 | -97.1 |
Other Investing Activities | -33.35 | 8.33 | 3.45 | 1.5 | 1.46 | 0.63 |
Investing Cash Flow | -499.08 | -558.62 | 2.73 | 20.45 | -1.14 | -104.82 |
Long-Term Debt Repaid | - | -5 | -9.33 | -8.4 | -12.44 | -16.1 |
Total Debt Repaid | -3.83 | -5 | -9.33 | -8.4 | -12.44 | -16.1 |
Net Debt Issued (Repaid) | 17.85 | -5 | -9.33 | -8.4 | -12.44 | -16.1 |
Issuance of Common Stock | 677.56 | 677.56 | - | - | - | - |
Other Financing Activities | -11.67 | -9.67 | -0.56 | 2.5 | -0.72 | 11.94 |
Financing Cash Flow | 683.74 | 662.89 | -9.89 | -5.9 | -13.16 | -4.16 |
Foreign Exchange Rate Adjustments | -0.68 | -0.47 | 1.53 | -0.77 | 1.01 | -0.42 |
Net Cash Flow | 87.81 | 67.75 | -50.1 | -55.59 | -66.18 | -138.58 |
Free Cash Flow | -96.27 | -36.45 | -47.77 | -71.38 | -53.98 | -37.4 |
Free Cash Flow Margin | -24.54% | -10.53% | -10.21% | -16.21% | -10.20% | -6.37% |
Free Cash Flow Per Share | -1.54 | -0.68 | -1.47 | -2.19 | -1.66 | -1.15 |
Cash Interest Paid | 0.07 | 0.07 | 0.21 | 0.08 | 0.23 | 0.39 |
Cash Income Tax Paid | 0.39 | 0.39 | 0.08 | -0.11 | -0.18 | 0.18 |
Levered Free Cash Flow | -660.1 | -20.46 | -34.74 | -28.2 | -50.35 | -15.51 |
Unlevered Free Cash Flow | -660.07 | -20.42 | -34.61 | -28.15 | -50.2 | -15.27 |
Change in Working Capital | -72.26 | 6.34 | -4.06 | -26.07 | 0.86 | 34.24 |